Metabolic · ~3 min read
Survodutide: What It Is, How It Works & What the Research Shows
Overview
Survodutide is an investigational dual glucagon and GLP-1 receptor agonist developed by Boehringer Ingelheim. GLP-1 activity reduces appetite, while glucagon activity increases energy expenditure and reduces liver fat. In a phase 2 obesity trial, participants who completed treatment lost up to about 19% of body weight at 46 weeks. It is also being studied for metabolic dysfunction-associated steatohepatitis (MASH), where early trials showed strong improvements in liver fat and fibrosis markers.
Why researchers study it
Weight loss
Up to about 19% weight loss in a phase 2 obesity trial.
Liver health (MASH)
Strong improvements in liver fat and fibrosis markers.
Energy expenditure
Glucagon activity is studied for raising calorie burn.
How it works
Investigational dual agonism targets appetite and metabolic signaling. Obesity and liver-disease studies examine different clinical outcomes.
Adamantane & the blood–brain barrier
Chemically attaching an adamantane group to a peptide can increase its lipid (fat) solubility. Researchers hypothesize that this modification may help certain compounds cross the tightly regulated blood–brain barrier. The effect depends on the specific modified molecule; greater lipid solubility alone does not establish brain delivery or clinical benefit. This does not apply automatically to the unmodified peptide and is not a reconstitution additive.
What the research shows
- Body-weight reduction has been investigated in supervised obesity trials.
- Liver-disease activity has been investigated in MASH trials.
Typical protocol
Reconstitute a 10 mg vial with 1 mL bacteriostatic water for 10 mg/mL. Typical range: 0.3–6.0 mg once weekly · once weekly, same day each week.
Potential benefits & side effects
Potential benefits
- Significant reduction in appetite and food noise
- Clinically meaningful weight loss
- Improved blood sugar and insulin sensitivity
- Improvements in blood pressure, lipids and liver fat
Side effects
- Nausea, vomiting, diarrhea or constipation (most common, usually during dose increases)
- Reduced appetite to the point of under-eating
- Fatigue and occasional headache
- Increased heart rate (especially triple/glucagon agonists)
- Rare: gallbladder problems or pancreatitis — seek care for severe abdominal pain
Lifestyle factors
- Protein: aim for adequate protein (about 0.7–1 g per lb of goal body weight) to preserve muscle during weight loss.
- Resistance training: lift 2–4x per week to protect lean mass.
- Hydration & fiber: drink plenty of water and eat fiber to reduce constipation and nausea.
- Meal size: eat smaller meals and stop at fullness; greasy, heavy meals worsen GI side effects.
- Titrate slowly: stay at a dose until side effects settle before increasing.